prednisone,polatuzumab,rituximab,doxorubicin
roche,abbvie
['lymsm', 'dlbcl', 'polarix']
congress #asco22 | of presents an analysis of peripheral neuropathy using clinician- and patient-reported outcomes from the phase iii polarix study these findings support the use of pola-r-chp among patients with previously untreated #dlbcl #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm